scholarly article | Q13442814 |
P2093 | author name string | Tao Peng | |
Yu Liang | |||
Long Yu | |||
Wei Qin | |||
Zhen Liu | |||
Xue Qin | |||
Zhiwei Chen | |||
Jiahong Dong | |||
Xiaoguang Liu | |||
Hao Su | |||
Guangzhi Zhu | |||
Zhengtao Liu | |||
Kaiyin Xiao | |||
Lequn Li | |||
Xinping Ye | |||
Chuangye Han | |||
Chengkun Yang | |||
Ketuan Huang | |||
Tingdong Yu | |||
Xiwen Liao | |||
Sicong Lu | |||
Jianlu Huang | |||
Minhao Peng | |||
P2860 | cites work | Global cancer statistics, 2012 | Q27860501 |
Management of hepatocellular carcinoma: An update | Q27860530 | ||
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations | Q28943370 | ||
Hepatocellular carcinoma pathogenesis: from genes to environment | Q29615767 | ||
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Q30984322 | ||
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma | Q33643368 | ||
TP53 mutations in human cancers: origins, consequences, and clinical use | Q33685392 | ||
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome | Q34016649 | ||
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 | Q34132629 | ||
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma | Q34162606 | ||
Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population | Q34193026 | ||
PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma | Q34393274 | ||
HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC) | Q34485939 | ||
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 | Q34533596 | ||
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. | Q34606896 | ||
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. | Q34721998 | ||
Phospholipase C epsilon 1 (PLCE1) haplotypes are associated with increased risk of gastric cancer in Kashmir Valley | Q34735909 | ||
Association between PLCE1 rs2274223 A > G polymorphism and cancer risk: proof from a meta-analysis | Q35003921 | ||
Associations of genetic variants in the PSCA, MUC1 and PLCE1 genes with stomach cancer susceptibility in a Chinese population | Q35057690 | ||
Genetic variants in the inositol phosphate metabolism pathway and risk of different types of cancer | Q35086684 | ||
HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells | Q35595069 | ||
Genetic variants and risk of gastric cancer: a pathway analysis of a genome-wide association study | Q35607223 | ||
PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling | Q35679578 | ||
Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. | Q35828537 | ||
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations | Q36284993 | ||
The association between phospholipase C epsilon gene (PLCE1) polymorphisms and colorectal cancer risk in a Chinese Han population: a case-control study | Q36412258 | ||
Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population | Q36412273 | ||
Phospholipase C epsilon: linking second messengers and small GTPases | Q36644946 | ||
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma | Q36738971 | ||
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes | Q36777326 | ||
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma | Q36782253 | ||
Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi | Q36879598 | ||
Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells | Q37012048 | ||
Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background | Q37376106 | ||
Regulatory links between PLC enzymes and Ras superfamily GTPases: signalling via PLCepsilon | Q37522224 | ||
A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis | Q37597313 | ||
Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors | Q37942529 | ||
Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis | Q38280688 | ||
Genetic variation and gastric cancer risk: a field synopsis and meta-analysis | Q38366774 | ||
MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. | Q38803090 | ||
Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells | Q38973941 | ||
PLCE1 suppresses p53 expression in esophageal cancer cells | Q39001251 | ||
Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population | Q39104291 | ||
Cancer survival in China, 2003-2005: a population-based study | Q39125586 | ||
Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness | Q39154242 | ||
shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo | Q39517920 | ||
RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line | Q39682004 | ||
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. | Q39808782 | ||
Cancer statistics in China, 2015. | Q40064386 | ||
Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. | Q40383044 | ||
ATXN7 Gene Variants and Expression Predict Post-Operative Clinical Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma. | Q40471844 | ||
Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer. | Q40593282 | ||
MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. | Q40807981 | ||
Two novel polymorphisms in PLCE1 are associated with the susceptibility to esophageal squamous cell carcinoma in Chinese population | Q40809713 | ||
Genetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles | Q41135952 | ||
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure | Q42241369 | ||
Heterozygote of PLCE1 rs2274223 increases susceptibility to human papillomavirus infection in patients with esophageal carcinoma among the Kazakh populations | Q42262374 | ||
Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development | Q42471916 | ||
Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China | Q42962258 | ||
GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology | Q43890876 | ||
Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma | Q44037227 | ||
Genetic association of PLCE1, C11orf92-C11orf93, and NOC3L with colorectal cancer risk in the Han population | Q44539939 | ||
Association of potentially functional genetic variants of PLCE1 with gallbladder cancer susceptibility in north Indian population. | Q44845225 | ||
Screening of new tumor suppressor genes in sporadic colorectal cancer patients. | Q45692871 | ||
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. | Q45846130 | ||
Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. | Q46003371 | ||
Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population | Q46491414 | ||
Phospholipase C ε-1 inhibits p53 expression in lung cancer | Q46677438 | ||
Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. | Q50979153 | ||
Phospholipase C epsilon 1 (PLCE1 rs2274223A>G, rs3765524C>T and rs7922612C>T) polymorphisms and esophageal cancer risk in the Kashmir Valley. | Q53235764 | ||
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways for gastric adenocarcinoma. | Q53614295 | ||
Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population. | Q54194242 | ||
A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition. | Q54206839 | ||
Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): a case-control study in eastern Chinese populations. | Q54332202 | ||
Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. | Q54365151 | ||
Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population. | Q54569106 | ||
Hepatocellular carcinoma | Q57756376 | ||
Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies | Q74009314 | ||
Association of 10q23 with colorectal cancer in a Chinese population | Q84475338 | ||
Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population | Q84490516 | ||
Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population | Q84752491 | ||
Genetic variant PLCE1 rs2274223 and gastric cancer: more to be explored? | Q85384702 | ||
Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition) | Q87054568 | ||
Association between phospholipase C epsilon gene (PLCE1) polymorphism and colorectal cancer risk in a Chinese population | Q87231590 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatectomy | Q1514021 |
P304 | page(s) | 29202-29219 | |
P577 | publication date | 2017-03-18 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy | |
P478 | volume | 8 |
Q47101417 | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict microvascular invasion in patients with hepatocellular carcinoma | cites work | P2860 |
Search more.